Diabetes Academy – What’s New in Diabetes University of Melbourne

Overview

What you will study

Diabetes management is rapidly evolving. Recent large randomized controlled cardiovascular outcome trials have provided the evidence for the introduction of a variety of new classes of medications available for use for people with type 2 diabetes. Advances in technology including the use of continuous glucose monitoring devices and insulin pumps are improving outcomes for people with type 1 diabetes.

This Diabetes Academy – What’s New in Diabetes course offered by University of Melbourne provides an evidence-based update for clinicians on the novel medications and emerging technologies available to improve outcomes in people with diabetes. Clinical case studies using video vignettes and multiple-choice questions are designed to optimise comprehension and learning.

Learning Outcomes

• Manage the comprehensive care of a patient with diabetes in order to prevent medication risks and reduce the risk of diabetes complications.
• Discuss the indications and benefits of novel medications in diabetes management, including GLP1 analogues, SGLT2 inhibitors and DPPIV inhibitors.
• Describe the current guidelines and management of diabetes in pregnancy.
• Use evidence-based guidelines for assessment and management of hypertension, including the use of Ambulatory Blood Pressure Monitoring.

• Evaluate the care of a patient with new technologies such as an insulin pump or continuous glucose monitoring device.